Massivemarkets

CRMD

CorMedix Inc.

Nasdaq · usd

$4.72-0.10 (-2.14%)
As of 2:29:16 PM EST on Nov 17, 2026 · 15-minute delayed

CorMedix Inc. (CRMD) trades at $4.72 (-2.14%) as of 2:29:16 PM EST on Nov 17, 2026, -36.04% over the past month. Market cap is $383.37M, with 8.4 days to cover in short interest.

Stock performance

How CorMedix Inc. (CRMD) stock has performed from one day to one year, with its 52-week range.

-1.97%
-$0.10 over 1D
$4.66$4.72$4.78$4.844:10 AM10:15 AM11:40 AM1:00 PM2:25 PM$4.73
1D
-2.07%
1W
-12.10%
1M
-36.04%
YTD
-59.42%
1Y
-53.15%
52-wk range
$4.64 – $13.02

Key statistics

Today's trading snapshot for CRMD: day range, open, previous close, volume and market cap.

Day range
$4.64 – $4.87
Open
$4.79
Prev close
$4.82
Volume
1.02M
Market cap
$383.37M
Shares out
79.54M

Valuation and profitability ratios: P/E, P/S, ROE

Valuation and profitability ratios for CorMedix Inc.: P/E, P/S, P/B, ROE and more.

P/E
6.00
P/S
0.93
P/B
0.83
P/FCF
1.25
ROE
13.8%
ROA
7.0%
Debt/Equity
0.00
Div yield
0.00%

As of Nov 16, 2026

8-K filings

Material corporate events CorMedix Inc. has disclosed to the SEC on Form 8-K.

  • Quarterly earningsNov 12, 2026

    On November 12, 2026, CorMedix Inc. (the "Company") issued a press release announcing its financial results for the quarter ended September 30, 2026.

  • Investor presentationNov 10, 2026

    In connection with the announcement, the Company hosted a conference call and webcast for investors on November 9, 2026, and made available an investor presentation regarding the transaction.

  • Acquisition consideration sharesNov 9, 2026

    As consideration for the Asset Sale, the Company has agreed to (i) issue to the Seller 14,583,333 shares of the Company's common stock ... (ii) pay to the Seller a purchase price equal to $145.0 million in cash ... [and] (iv) pay to the Seller earn-out payments of $25.0 million ... and an additional $30.0 million ... payable at the Company's election in cash, shares of Common Stock or a combination thereof.

  • Business updateNov 2, 2026

    On November 2, 2026, the Company issued a press release providing a business update and announcing the Company's cash position for the quarter ended September 30, 2026.

  • On October 19, 2026, CorMedix, Inc. issued a press release announcing that the U.S. Food and Drug Administration (FDA) has accepted for filing the supplemental New Drug Application (sNDA) seeking approval of REZZAYO® (rezafungin for injection) for the prophylaxis of invasive fungal disease.

Dividend history and stock splits

CorMedix Inc.'s recent dividend payments and stock splits.

Dividends

No recent dividends.

Splits

  • 1-for-5Mar 26, 2019

CRMD short interest

How heavily CRMD is shorted: shares short, days to cover and average daily volume.

Days to cover
8.4
Short interest
14.21M
Avg volume
1.68M

As of · reported to FINRA twice monthly.

CRMD news

The latest news and headlines about CorMedix Inc. (CRMD).

Frequently asked questions

What is the CorMedix Inc. (CRMD) stock price today?

CorMedix Inc. (CRMD) is trading at $4.72 (-2.14% on the day) as of 2:29:16 PM EST on Nov 17, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

What is CorMedix Inc.?

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets.

What is the short interest in CRMD?

As of Oct 30, 2026, CRMD has 14.21M shares short and 8.4 days to cover.

What exchange is CRMD listed on?

CorMedix Inc. (CRMD) trades on Nasdaq in USD, in the PHARMACEUTICAL PREPARATIONS industry.

Build with AI

Build an analysis of CRMD with your agent

Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.

Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a CRMD analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.

Live market data from the Massive API and MCP.Get a free API key

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.